Police in central China's Henan province have recently cracked a case in which counterfeit asthma capsules were sold via telephone or mail, the People's Daily reported on Saturday. Local police and drug regulator found the names of manufacturers and qualification codes of six capsules, mostly used for the treatment of asthma, arthritis and rheumatism, were fabricated. Following the case, the State Food and Drug Administration (SFDA) has warned the public to be cautious against underground drug sales channels. The case is the latest phoney drug scandal uncovered by local police after a raid on an illegal drug production and sale network in October that ended up with the seizure of 190 million yuan (29.9 million U.S. dollars) worth of counterfeit drugs. Chinese authorities have announced several major crackdowns this year after safety scandals broke out involving items ranging from drugs to wine. Among them was a high-profile national campaign starting November last year to crack down on the violations of intellectual property rights and the production and distribution of fraudulent and shoddy products.
GMT 18:06 2018 Tuesday ,09 January
10 migrants dead, dozens missing off Libya coastGMT 22:05 2018 Wednesday ,03 January
US says airstrike kills 2 militants in SomaliaGMT 18:56 2018 Wednesday ,03 January
Philippines prohibits US firm call center from expanding after deadly fireGMT 17:03 2018 Wednesday ,03 January
Severe storm batters western Europe; 1 dead, 15 injuredGMT 16:32 2018 Wednesday ,03 January
Palestinian shot dead in West Bank clashes with Israeli army: ministryGMT 11:49 2018 Wednesday ,03 January
Russian helicopter crashes in Syria, two dead: MoscowGMT 17:22 2017 Thursday ,28 December
10 hurt in Saint Petersburg supermarket bombingGMT 17:49 2017 Wednesday ,27 December
Blast in Saint Petersburg injures four, say officials
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor